rethinkPeptides Search
Menu
Research citation

Biodegradable Nanoparticles Containing Mechanism Based Peptide Inhibitors Reduce Polyglutamine Aggregation in Cell Models and Alleviate Motor Symptoms in a Drosophila Model of Huntington's Disease.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Biodegradable Nanoparticles Containing Mechanism Based Peptide Inhibitors Reduce Polyglutamine Aggregation in Cell Models and Alleviate Motor Symptoms in a Drosophila Model of Huntington's Disease.

ACS chemical neuroscience, 10(3), 1603-1614

Citation

Joshi, Abhayraj S; Singh, Virender; Gahane, Avinash; Thakur, Ashwani Kumar. (2019). Biodegradable Nanoparticles Containing Mechanism Based Peptide Inhibitors Reduce Polyglutamine Aggregation in Cell Models and Alleviate Motor Symptoms in a Drosophila Model of Huntington's Disease.. ACS chemical neuroscience, 10(3), 1603-1614. https://doi.org/10.1021/acschemneuro.8b00545